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Background
Currently, immunogenicity assessments of candidate
HIV-1 vaccines in human clinical trials rely on the use
of peptides for sensitization of target cells. However,
employment of HIV-1-infected cells provides more
informative and relevant in vitro readouts of HIV-1
recognition.
Methods
A viral suppression assay (VSA) was developed to assess
CD8+ T cell responses to infected autologous CD4+ tar-
gets using HIV-1 p24 levels as measured by flow cytome-
try and ELISA. In parallel, we also investigated live virus
infected cells for re-stimulation of vaccine elicited T cells
in an IFN-g ELISpot assay.
Results
HIV-1 infection kinetics is influenced by the multiplicity
of infection (MOI) used to infect autologous CD4+ cells,
with rapid kinetics observed at higher MOIs. For HIV-1
BaL optimal infection of autologous CD4+ cells was
achieved at MOI of 0.05. In the VSA, HIV-1 BaL virus
replication was shown to be sensitive to the chemokines
MIP-1a and RANTES added in the absence of effector
cells. Pre-activated effector cells indicated increased non-
specific background suppression in healthy controls,
which was reduced following a prolonged rest before co-
culture with autologous CD4+ targets, but led to marked
proliferation of the CD8+ T cell effectors. Preliminary
investigations in vaccinees show that HIV-1 suppression
mediated by CD8+ T cells can be detected in vitro fol-
lowing vaccination and that P24 ELISA has higher sensi-
tivity than flow cytometry. As an alternative to the VSA,
an IFN-g ELISpot assay has also been optimized for the
use of autologous HIV-1-infected CD4+ cells. Using both
of the above assays, preliminary characterization of T cell
responses induced in volunteers receiving pSG2.HIV-
consv DNA, MVA.HIVconsv and ChAdV63.HIVconsv
vaccines will be shown.
Conclusion
Two assays employing HIV-1 infected target cells were
standardised and employed to characterize responses
elicited in participants of the HIV-1 vaccine trial HIV-
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